Cas 1425926-80-2,N-cyclohexyl-3-methyl-2-oxo-1,2,3,4-tetrahydro-quinazoline-6-sulfonamide

1425926-80-2

Post Buying Request

Basic information

Product Name: N-cyclohexyl-3-methyl-2-oxo-1,2,3,4-tetrahydro-quinazoline-6-sulfonamide
Synonyms: N-cyclohexyl-3-methyl-2-oxo-1,2,3,4-tetrahydro-quinazoline-6-sulfonamide
CAS NO:1425926-80-2
Molecular Formula:
Molecular Weight: 323.416
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-cyclohexyl-3-methyl-2-oxo-1,2,3,4-tetrahydro-quinazoline-6-sulfonamide(CAS DataBase Reference)
NIST Chemistry Reference: N-cyclohexyl-3-methyl-2-oxo-1,2,3,4-tetrahydro-quinazoline-6-sulfonamide(1425926-80-2)
EPA Substance Registry System: N-cyclohexyl-3-methyl-2-oxo-1,2,3,4-tetrahydro-quinazoline-6-sulfonamide(1425926-80-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1425926-80-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1425926-80-2 Suppliers

Recommended suppliers

1425926-80-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1425926-80-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,2,5,9,2 and 6 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1425926-80:
(9*1)+(8*4)+(7*2)+(6*5)+(5*9)+(4*2)+(3*6)+(2*8)+(1*0)=172
172 % 10 = 2
So 1425926-80-2 is a valid CAS Registry Number.

1425926-80-2Upstream product

1425926-80-2Downstream Products

1425926-80-2Relevant academic research and scientific papers

NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS

-

Page/Page column 41, (2013/03/26)

Disclosed are compounds of Formula (I): (I) which are useful as bromodomain inhibitors. Pharmaceutical compositions containing compounds of Formula (I) and the use of compounds of Formula (I) to treat diseases or disorders that are bromodomain-dependent are also disclosed. Methods for preparing and using these compounds are further described.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1425926-80-2